Oncologic risks of autologous fat grafting to the breast.
As the frequency of fat grafting to the breast has increased, some investigators have raised the possibility that this procedure may potentially increase the risks associated with breast cancer. Their concerns included not only interference with cancer detection, but also promotion of tumor formation or recurrence mediated by mechanisms such as aromatase expression, angiogenesis, and tumor stromal cells. However, published clinical studies describing outcomes of fat grafting to the breast in more than 2000 patients have not reported any increase in new or recurrent cancers. The reason for this apparent disconnect may lie in the small sample sizes and relatively short follow-up, but it may also reside in the considerable gap between laboratory studies or theoretical considerations suggesting potential risks and the actual clinical practice. This review discusses potential risks of current and novel approaches to autologous fat grafting to the breast within the context of both the underlying science and clinical practice.
Cytori Therapeutics Inc., San Diego, CA, USA.
John K
JK
Fraser
Marc H
MH
Hedrick
Steven R
SR
Cohen
D000273:Adipose Tissue / Q000637:transplantation*; D000818:Animals; D001141:Aromatase / Q000235:genetics; D001943:Breast Neoplasms / Q000175:diagnosis / Q000209:etiology*; D005260:Female; D005786:Gene Expression Regulation; D006801:Humans; D016462:Mammaplasty / Q000009:adverse effects* / Q000379:methods; D009364:Neoplasm Recurrence, Local; D009389:Neovascularization, Pathologic / Q000209:etiology; D012306:Risk; D014182:Transplantation, Autologous
D001141:Aromatase